Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Leukemia Inhibitory Factor (LIF) Peptide

LIF Reactivity: Mammalian Host: Synthetic BP, WB, IHC
Catalog No. ABIN940098
  • Target See all LIF products
    LIF (Leukemia Inhibitory Factor (LIF))
    Peptide Type
    Synthetic
    Origin
    Mammalian
    Source
    • 6
    Synthetic
    Application
    Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
    Sequence
    KVLAAGVVPL LLVLHWKHGA GSPLPITPVN ATCAIRHPCH NNLMNQIRSQ
    Characteristics
    A synthetic peptide for use as a blocking control in assays to test for specificity of LIF antibody,
    Alternative Names: LIF control peptide, LIF antibody Blocking Peptide, Anti-LIF Blocking Peptide, Leukemia Inhibitory Factor Blocking Peptide, Cholinergic Differentiation Factor Blocking Peptide, CDF Blocking Peptide, D-FACTOR Blocking Peptide, HILDA Blocking Peptide
  • Application Notes
    Optimal conditions should be determined by the investigator
    Restrictions
    For Research Use only
  • Format
    Lyophilized
    Reconstitution
    Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
    Buffer
    PBS
    Handling Advice
    Avoid repeated freeze/thaw cycles.
    Storage
    -20 °C
    Storage Comment
    Store at -20 °C long term.
  • Target
    LIF (Leukemia Inhibitory Factor (LIF))
    Synonyms
    CDF Peptide, DIA Peptide, HILDA Peptide, MLPLI Peptide, LIF, interleukin 6 family cytokine Peptide, leukemia inhibitory factor Peptide, LIF Peptide, Lif Peptide
    Background
    LIF is a pleiotropic cytokine with roles in several different systems. It is involved in the induction of hematopoietic differentiation in normal and myeloid leukemia cells, induction of neuronal cell differentiation, regulator of mesenchymal to epithelial conversion during kidney development, and may also have a role in immune tolerance at the maternal-fetal interface.
    Molecular Weight
    22 kDa
You are here:
Support